OCC 8.11% 40.0¢ orthocell limited

Ann: First Patients Complete Nerve Regeneration Trial, page-396

  1. 4,434 Posts.
    lightbulb Created with Sketch. 637
    But this doesn't come cheap Kate, fda approved on final third trial.
    So say no more, did you miss the boat? $$$
    Last edited by Telluride: 09/05/19
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.